Heparin Ineffective At Preventing Blood Clots In Pregnant Women
For two decades, women at risk of developing placental blood clots have been prescribed the anticoagulant low molecular weight heparin (LMWH) but it's ineffective, according to a clinical trial published today in The Lancet.
As many as one in 10 pregnant women have a tendency to develop thrombophilia
- blood clots in their vein. These women have been injected with LMWH daily, which means hundreds of needles over the course of their pregnancy.
A randomized clinical trial led by Dr. Marc Rodger, a senior scientist at the Ottawa Hospital Research Institute who heads up the…